Pretreatment Prostate-Specific Antigen (PSA) Velocity and Doubling Time Are Associated With Outcome but Neither Improves Prediction of Outcome Beyond Pretreatment PSA Alone in Patients Treated With Radical Prostatectomy

PURPOSE: Controversy exists as to whether current pretreatment prostate-specific antigen (PSA) dynamics enhance outcome prediction in patients undergoing treatment for prostate cancer. We assessed whether pretreatment PSA velocity (PSAV) or doubling time (PSADT) predicted outcome in men undergoing r...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: O'Brien, Matthew Frank, Cronin, Angel M., Fearn, Paul A., Smith, Brandon, Stasi, Jason, Guillonneau, Bertrand, Scardino, Peter T., Eastham, James A., Vickers, Andrew J., Lilja, Hans
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2009
Assuntos:
Original Reports
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2720078/
https://ncbi.nlm.nih.gov/pubmed/19506163
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2008.19.9794
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados